LVAD therapy as a catalyst to heart failure remission and myocardial recovery

The management of chronic heart failure over the past decade has witnessed tremendous strides in medical optimization and device therapy including the use of left ventricular assist devices (LVAD). What we once thought of as irreversible damage to the myocardium is now demonstrating signs of reverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamad, Eman A., Byku, Mirnela, Larson, Sharon B., Billia, Filio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577530/
https://www.ncbi.nlm.nih.gov/pubmed/37526373
http://dx.doi.org/10.1002/clc.24094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577530/
https://www.ncbi.nlm.nih.gov/pubmed/37526373
http://dx.doi.org/10.1002/clc.24094

Ejemplares similares